Selected research
Industry Research
Penfluridol Industry Research Report 2026
Market perspective
The global Penfluridol market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Penfluridol is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Penfluridol is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Penfluridol is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Penfluridol include Chongqing Qingyang Pharmaceutical, Sun Pharmaceutical Industries, Sphsine Pharm, Kamp, Jiangsu Nhwa Pharmaceutical, Hunan Zhongnan Pharm, Hunan DongtingPharm, Harbin Pharmaceutical Group and Fuhe Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Penfluridol market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Penfluridol Market by Company
Chongqing Qingyang Pharmaceutical
Sun Pharmaceutical Industries
Sphsine Pharm
Kamp
Jiangsu Nhwa Pharmaceutical
Hunan Zhongnan Pharm
Hunan DongtingPharm
Harbin Pharmaceutical Group
Fuhe Group
Taj Pharmaceuticals
Lifecare Neuro Products
Enomark
Dr. Reddy's Laboratories
Penfluridol Segment by Type
Tablets
Capsules
Penfluridol Segment by Application
Hospital
Clinic
Pharmacy
Penfluridol Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Penfluridol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Penfluridol and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Penfluridol.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Penfluridol manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Penfluridol by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Penfluridol in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablets
- Capsules
Applications
- Hospital
- Clinic
- Pharmacy
Companies covered
- Chongqing Qingyang Pharmaceutical
- Sun Pharmaceutical Industries
- Sphsine Pharm
- Kamp
- Jiangsu Nhwa Pharmaceutical
- Hunan Zhongnan Pharm
- Hunan DongtingPharm
- Harbin Pharmaceutical Group
- Fuhe Group
- Taj Pharmaceuticals
- Lifecare Neuro Products
- Enomark
- Dr. Reddy's Laboratories
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Penfluridol Market Size (2021-2032)
- 2.2.2 Global Penfluridol Sales (2021-2032)
- 2.2.3 Global Penfluridol Market Average Price (2021-2032)
- 2.3 Penfluridol by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Tablets
- 2.3.3 Capsules
- 2.4 Penfluridol by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Pharmacy
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Penfluridol Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Penfluridol Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Penfluridol Revenue of Manufacturers (2021-2026)
- 3.4 Global Penfluridol Average Price by Manufacturers (2021-2026)
- 3.5 Global Penfluridol Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Penfluridol, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Penfluridol, Product Type & Application
- 3.8 Global Manufacturers of Penfluridol, Established Date
- 3.9 Global Penfluridol Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Chongqing Qingyang Pharmaceutical
- 4.1.1 Chongqing Qingyang Pharmaceutical Company Information
- 4.1.2 Chongqing Qingyang Pharmaceutical Business Overview
- 4.1.3 Chongqing Qingyang Pharmaceutical Penfluridol Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Chongqing Qingyang Pharmaceutical Penfluridol Product Portfolio
- 4.1.5 Chongqing Qingyang Pharmaceutical Recent Developments
- 4.2 Sun Pharmaceutical Industries
- 4.2.1 Sun Pharmaceutical Industries Company Information
- 4.2.2 Sun Pharmaceutical Industries Business Overview
- 4.2.3 Sun Pharmaceutical Industries Penfluridol Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sun Pharmaceutical Industries Penfluridol Product Portfolio
- 4.2.5 Sun Pharmaceutical Industries Recent Developments
- 4.3 Sphsine Pharm
- 4.3.1 Sphsine Pharm Company Information
- 4.3.2 Sphsine Pharm Business Overview
- 4.3.3 Sphsine Pharm Penfluridol Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Sphsine Pharm Penfluridol Product Portfolio
- 4.3.5 Sphsine Pharm Recent Developments
- 4.4 Kamp
- 4.4.1 Kamp Company Information
- 4.4.2 Kamp Business Overview
- 4.4.3 Kamp Penfluridol Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Kamp Penfluridol Product Portfolio
- 4.4.5 Kamp Recent Developments
- 4.5 Jiangsu Nhwa Pharmaceutical
- 4.5.1 Jiangsu Nhwa Pharmaceutical Company Information
- 4.5.2 Jiangsu Nhwa Pharmaceutical Business Overview
- 4.5.3 Jiangsu Nhwa Pharmaceutical Penfluridol Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Jiangsu Nhwa Pharmaceutical Penfluridol Product Portfolio
- 4.5.5 Jiangsu Nhwa Pharmaceutical Recent Developments
- 4.6 Hunan Zhongnan Pharm
- 4.6.1 Hunan Zhongnan Pharm Company Information
- 4.6.2 Hunan Zhongnan Pharm Business Overview
- 4.6.3 Hunan Zhongnan Pharm Penfluridol Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Hunan Zhongnan Pharm Penfluridol Product Portfolio
- 4.6.5 Hunan Zhongnan Pharm Recent Developments
- 4.7 Hunan DongtingPharm
- 4.7.1 Hunan DongtingPharm Company Information
- 4.7.2 Hunan DongtingPharm Business Overview
- 4.7.3 Hunan DongtingPharm Penfluridol Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Hunan DongtingPharm Penfluridol Product Portfolio
- 4.7.5 Hunan DongtingPharm Recent Developments
- 4.8 Harbin Pharmaceutical Group
- 4.8.1 Harbin Pharmaceutical Group Company Information
- 4.8.2 Harbin Pharmaceutical Group Business Overview
- 4.8.3 Harbin Pharmaceutical Group Penfluridol Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Harbin Pharmaceutical Group Penfluridol Product Portfolio
- 4.8.5 Harbin Pharmaceutical Group Recent Developments
- 4.9 Fuhe Group
- 4.9.1 Fuhe Group Company Information
- 4.9.2 Fuhe Group Business Overview
- 4.9.3 Fuhe Group Penfluridol Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Fuhe Group Penfluridol Product Portfolio
- 4.9.5 Fuhe Group Recent Developments
- 4.10 Taj Pharmaceuticals
- 4.10.1 Taj Pharmaceuticals Company Information
- 4.10.2 Taj Pharmaceuticals Business Overview
- 4.10.3 Taj Pharmaceuticals Penfluridol Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Taj Pharmaceuticals Penfluridol Product Portfolio
- 4.10.5 Taj Pharmaceuticals Recent Developments
- 4.11 Lifecare Neuro Products
- 4.11.1 Lifecare Neuro Products Company Information
- 4.11.2 Lifecare Neuro Products Business Overview
- 4.11.3 Lifecare Neuro Products Penfluridol Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Lifecare Neuro Products Penfluridol Product Portfolio
- 4.11.5 Lifecare Neuro Products Recent Developments
- 4.12 Enomark
- 4.12.1 Enomark Company Information
- 4.12.2 Enomark Business Overview
- 4.12.3 Enomark Penfluridol Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Enomark Penfluridol Product Portfolio
- 4.12.5 Enomark Recent Developments
- 4.13 Dr. Reddy's Laboratories
- 4.13.1 Dr. Reddy's Laboratories Company Information
- 4.13.2 Dr. Reddy's Laboratories Business Overview
- 4.13.3 Dr. Reddy's Laboratories Penfluridol Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Dr. Reddy's Laboratories Penfluridol Product Portfolio
- 4.13.5 Dr. Reddy's Laboratories Recent Developments
5 Global Penfluridol Market Scenario by Region
- 5.1 Global Penfluridol Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Penfluridol Sales by Region: 2021-2032
- 5.2.1 Global Penfluridol Sales by Region: 2021-2026
- 5.2.2 Global Penfluridol Sales by Region: 2027-2032
- 5.3 Global Penfluridol Revenue by Region: 2021-2032
- 5.3.1 Global Penfluridol Revenue by Region: 2021-2026
- 5.3.2 Global Penfluridol Revenue by Region: 2027-2032
- 5.4 North America Penfluridol Market Facts & Figures by Country
- 5.4.1 North America Penfluridol Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Penfluridol Sales by Country (2021-2032)
- 5.4.3 North America Penfluridol Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Penfluridol Market Facts & Figures by Country
- 5.5.1 Europe Penfluridol Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Penfluridol Sales by Country (2021-2032)
- 5.5.3 Europe Penfluridol Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Penfluridol Market Facts & Figures by Country
- 5.6.1 Asia Pacific Penfluridol Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Penfluridol Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Penfluridol Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Penfluridol Market Facts & Figures by Country
- 5.7.1 South America Penfluridol Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Penfluridol Sales by Country (2021-2032)
- 5.7.3 South America Penfluridol Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Penfluridol Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Penfluridol Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Penfluridol Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Penfluridol Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Penfluridol Sales by Type (2021-2032)
- 6.1.1 Global Penfluridol Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Penfluridol Sales Market Share by Type (2021-2032)
- 6.2 Global Penfluridol Revenue by Type (2021-2032)
- 6.2.1 Global Penfluridol Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Penfluridol Revenue Market Share by Type (2021-2032)
- 6.3 Global Penfluridol Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Penfluridol Sales by Application (2021-2032)
- 7.1.1 Global Penfluridol Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Penfluridol Sales Market Share by Application (2021-2032)
- 7.2 Global Penfluridol Revenue by Application (2021-2032)
- 7.2.1 Global Penfluridol Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Penfluridol Revenue Market Share by Application (2021-2032)
- 7.3 Global Penfluridol Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Penfluridol Value Chain Analysis
- 8.1.1 Penfluridol Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Penfluridol Production Mode & Process
- 8.2 Penfluridol Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Penfluridol Distributors
- 8.2.3 Penfluridol Customers
9 Global Penfluridol Analyzing Market Dynamics
- 9.1 Penfluridol Industry Trends
- 9.2 Penfluridol Industry Drivers
- 9.3 Penfluridol Industry Opportunities and Challenges
- 9.4 Penfluridol Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst